Age‐associated obesity and muscle atrophy (sarcopenia) are intimately connected and are
reciprocally regulated by adipose tissue and skeletal muscle dysfunction. During ageing …

The rapid and widespread clinical adoption of highly effective incretin‐mimetic drugs (IMDs),
particularly semaglutide and tirzepatide, for the treatment of obesity has outpaced the …

BACKGROUND The coexistence of sarcopenia and obesity is referred to as sarcopenic
obesity (SO) and it has been hypothesized that the two components of SO may …

Lower muscle mass in populations with obesity is associated obesity-related diseases like
hypertension and type 2 diabetes mellitus. Bariatric surgery leads to sustained weight loss …

Purpose Sarcopenia and diabetes are two common conditions in older people. Some recent
literature has proposed that these two conditions can be associated. However, to date, no …

Normal-weight obesity (NWO) is a phenotype characterized by excessive body fat (BF)
despite normal body weight. We aimed to assess the association between NWO and the risk …

Little is known about the reduction in lean body mass (LBM) and its health consequences in
overweight and in obesity, especially in males. Therefore, we aimed to assess the …

The relationship between hyperhomocysteinemia (HHcy) and obesity with low skeletal
muscle mass (LMM) has not been established. We aim to assess the association between …

Obesity affects several areas of the human body, leading to increased morbidity and
mortality and the likelihood of other diseases, such as type 2 diabetes mellitus …

Background and Aim: Research interests in a new phenotype termed as sarcopenic obesity
(SO), which refers to a decrease in lean body mass and muscle strength associated with an …